In-practice evaluation of OraVerse
for the reversal of soft-tissue anesthesia after dental procedures.
4 'adjust pH' * CETRAXAL (ciprofloxacin) solution/ drops; Oraverse
(Phentolamine mesylate) injection, solution for submucosal use; RiaSTAP (fibrinogen human) injection, powder, lyophilized, for solution * Adjust the pH 'pH X and above'; * APRISO (mesalamine) capsule, 'pH X or greater' extended release * At pH 6 and above 'pH X' * Elspar (Asparaginase) powder, for solution; Oncaspar (pegaspargase) injection, solution for intramuscular and intravenous use * At pH 7.
Thus, phentolamine mesylate, marketed as OraVerse
, is not an antagonist of the local anesthetic itself but of the epinephrine.
4 reversal (phentolamine mg of phentolamine mesylate at the same mesylate) site, and with the same dose as a local * OraVerse
anesthetic with vasoconstrictor, can expect a significantly reduced duration of soft-tissue anesthesia (approximately 54.
comes in a standard dental cartridge and is easily injected utilizing the same injection site and technique as that used for local anesthetic.